. . . . . . . "[We also confirmed that the existing anti-inflammatory compounds inhibited the abnormal IL-1? secretion, indicating that mutant iPS-MPs are applicable for drug screening for CINCA syndrome and other NLRP3-related inflammatory conditions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:45+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .